Omnicell Inc (OMCL) is a publicly traded Healthcare sector company. As of July 14, 2026, OMCL trades at $46.77 with a market cap of $2.04B and a P/E ratio of 105.81. OMCL moved +3.87% today. Year to date, OMCL is +1.66%; over the trailing twelve months it is +62.70%. Its 52-week range spans $22.66 to $55.00. Analyst consensus is strong buy with an average price target of $65.00. Rallies surfaces OMCL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for OMCL combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $46.77 |
| Market Cap | $2.04B |
| P/E Ratio | 105.81 |
| EPS | $0.44 |
| Dividend Yield | 0.00% |
| 52-Week High | $55.00 |
| 52-Week Low | $22.66 |
| Volume | 462.94K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.23B |
| Net Income | $20.43M |
| Gross Margin | 43.50% |
5 analysts cover OMCL: 0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $65.00.